Receptor: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 13: Line 13:
'''The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study<ref>DOI 10.1080/07391102.2012.680029</ref>'''
'''The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study<ref>DOI 10.1080/07391102.2012.680029</ref>'''


The serotonin type-3 receptor (5-HT3-R) is a cation selective transmembrane protein channel that belongs to the Cys–loop Ligand-Gated Ion Channel (LGIC) superfamily (http://www.ebi.ac.uk/compneur-srv/LGICdb/LGICdb.php), which also includes receptors for nicotinic acetylcholine (<scene name='Journal:JBSD:16/Cv/2'>nAChR</scene>, PDB code [[2bg9]]), &#947;-aminobutyric acid and glycine. 5-HT3-R is involved in signal transmission in the central and peripheral nervous system and its malfunctioning leads to neurodegenerative and psychiatric diseases, therefore it is an important target for drug design research. A few drugs active against 5-HT3-R are already on the market, such as, for example, palonosetron (http://en.wikipedia.org/wiki/Palonosetron) and granisetron (http://en.wikipedia.org/wiki/Granisetron).  
The serotonin type-3 receptor (5-HT3-R) is a cation selective transmembrane protein channel that belongs to the Cys–loop Ligand-Gated Ion Channel (LGIC) superfamily (http://www.ebi.ac.uk/compneur-srv/LGICdb/LGICdb.php), which also includes receptors for nicotinic acetylcholine, &#947;-aminobutyric acid and glycine. 5-HT3-R is involved in signal transmission in the central and peripheral nervous system and its malfunctioning leads to neurodegenerative and psychiatric diseases, therefore it is an important target for drug design research. A few drugs active against 5-HT3-R are already on the market, such as, for example, palonosetron (http://en.wikipedia.org/wiki/Palonosetron) and granisetron (http://en.wikipedia.org/wiki/Granisetron).  
The 5-HT3R is made of five monomers assembled in a <scene name='Journal:JBSD:16/Cv/4'>pseudo-symmetric pentameric shape</scene> to form an ion channel permeable to small ions (Na+, K+); each subunit contains three domains: an <scene name='Journal:JBSD:16/Cv/3'>intracellular portion, a transmembrane domain and an extracellular region</scene> (shown on the example of nAChR, [[2bg9]]). To date, five different 5-HT3-R subunits have been identified, the 5-HT3 A, B, C, D and E; however, only subunits A and B have been extensively characterised experimentally. The <scene name='Journal:JBSD:16/Cv/6'>ligand binding site</scene> of nAChR is located at the extracellular region, at the interface between two monomers (α-γ and α-δ; 2 identical α monomers, chains A and D, are colored in same color - lavender), called the principal and the complementary subunits.  
The 5-HT3R is made of five monomers assembled in a <scene name='Journal:JBSD:16/Cv/4'>pseudo-symmetric pentameric shape</scene> to form an ion channel permeable to small ions (Na+, K+); each subunit contains three domains: an <scene name='Journal:JBSD:16/Cv/3'>intracellular portion, a transmembrane domain and an extracellular region</scene> (shown on the example of nAChR, [[2bg9]]). To date, five different 5-HT3-R subunits have been identified, the 5-HT3 A, B, C, D and E; however, only subunits A and B have been extensively characterised experimentally. The <scene name='Journal:JBSD:16/Cv/6'>ligand binding site</scene> of nAChR is located at the extracellular region, at the interface between two monomers (α-γ and α-δ; 2 identical α monomers, chains A and D, are colored in same color - lavender), called the principal and the complementary subunits.  
The 3D structure of 5-HT3-R has not been experimentally solved yet; however, it has been obtained computationally by means of homology modelling techniques. (http://salilab.org/modeller/)
The 3D structure of 5-HT3-R has not been experimentally solved yet; however, it has been obtained computationally by means of homology modelling techniques. (http://salilab.org/modeller/)

Revision as of 13:39, 13 April 2021

Nicotinic Acetylcholine Receptor, PDB code 2bg9

Drag the structure with the mouse to rotate

References

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky